A Phase 1b/2, Randomised, Placebo-controlled Study to Evaluate Safety, Tolerability, Efficacy, and Immunogenicity of VTP-200, a Chimpanzee Adenovirus and Modified Vaccinia Ankara-vectored Multigenotype High-risk Human Papillomavirus Vaccine in Women

A heterologous, multi-antigenic HPV two-component immunotherapy regimen was well-tolerated and immunogenic but did not result in a statistically significant clearance of either hrHPV or the associated cervical lesions in women with persistent high-risk HPV infections.

Authors

Institutions

Publication Details

Journal
Clinical Infectious Diseases
Published
2025-12-09
DOI
https://doi.org/10.1093/cid/ciaf658
Primary Topic
Cervical Cancer and HPV Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Phase 1b/2, Randomised, Placebo-controlled Study to Evaluate Safety, Tolerability, Efficacy, and Immunogenicity of VTP-200, a Chimpanzee Adenovirus and Modified Vaccinia Ankara-vectored Multigenotype High-risk Human Papillomavirus Vaccine in Women

Katie Anderson, Thomas G. Evans, Vicky Wheeler, Sarah Sebastian et al.
Clinical Infectious Diseases
Cervical Cancer and HPV Research
article

A Phase 1b/2, Randomised, Placebo-controlled Study to Evaluate Safety, Tolerability, Efficacy, and Immunogenicity of VTP-200, a Chimpanzee Adenovirus and Modified Vaccinia Ankara-vectored Multigenotype High-risk Human Papillomavirus Vaccine in Women

Katie Anderson, Thomas G. Evans, Vicky Wheeler, Sarah Sebastian, Gemma Hancock, Kobe Dewilde, Paula Briggs, Kate Cuschieri, Lucy Dorrell, Charlotte Davis, Dereck Tait, P. De Sutter, Karin Hellner, Philipp W. Simon, Antonella Vardeu, Kadri-Liina Vahula, Bethan Jones, Matthew Downs, Michelle Russell, Jakub Kopycinski, Claire Newton, Raisha Kennerley, Ülle Kiisla
article en

Abstract

A heterologous, multi-antigenic HPV two-component immunotherapy regimen was well-tolerated and immunogenic but did not result in a statistically significant clearance of either hrHPV or the associated cervical lesions in women with persistent high-risk HPV infections.

Clinical Infectious Diseases
University of Liverpool (GB), Universitair Ziekenhuis Leuven (BE), Royal Victoria Infirmary (GB), Women's and Children's Hospital (AU), Directorate-General for Health and Food Safety (BE), Newcastle upon Tyne Hospitals NHS Foundation Trust (GB), Erasmus Hospital (BE), Edinburgh Royal Infirmary (GB), University of Oxford (GB), North Estonia Medical Centre (EE), Clinique Saint Jean (BE), St Michael's Hospital (GB), Atara Biotherapeutics (United States) (US), Liverpool Womens NHS Foundation Trust (GB), KU Leuven (BE)
Openalex Percentile: Top 48%
Cervical Cancer and HPV Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.